Cazanat 20 Cabozantinib Tablets

About Cazanat 20 Cabozantinib Tablets

Cazanat 20 Tablets contain Cabozantinib, a targeted anticancer medication used in the treatment of certain advanced cancers. Cabozantinib is a tyrosine kinase inhibitor (TKI) that works by blocking specific proteins responsible for cancer cell growth, angiogenesis (formation of blood vessels), and tumor spread.

Cazanat 20 is commonly prescribed for the management of advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and other indicated solid tumors as advised by an oncologist. It helps slow disease progression and improve clinical outcomes when used under proper medical supervision.

• Effective targeted therapy for advanced cancers

• Helps inhibit tumor growth and spread

• Oral tablet for convenient administration

• Manufactured under strict quality standards

• Renal Cell Carcinoma (RCC)

• Hepatocellular Carcinoma (HCC)

• Other solid tumors (as prescribed)

Dosage should be taken strictly as prescribed by the oncologist. Tablets should be swallowed whole with water and not crushed or chewed.

• Store in a cool, dry place

• Keep away from direct sunlight

• Keep out of reach of children

• For prescription use only

• Not to be used during pregnancy or breastfeeding unless advised

• Patients should be monitored regularly during treatment